Rating History for Supernus Pharmaceuticals (SUPN) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for SUPN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/27/2026 Pavan Patel Maintain Buy
(N/A)		 62.00
(65.00)		  
 		   Details